Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms. [PDF]
Conn K +9 more
europepmc +1 more source
Pharmacological fingerprint of antipsychotic drugs at the serotonin 5-HT<sub>2A</sub> receptor. [PDF]
Gaitonde SA +11 more
europepmc +1 more source
G protein-specific mechanisms in the serotonin 5-HT<sub>2A</sub> receptor regulate psychosis-related effects and memory deficits. [PDF]
Kossatz E +19 more
europepmc +1 more source
Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists. [PDF]
M Ro Rsted E +4 more
europepmc +1 more source
Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player? [PDF]
Sekssaoui M +3 more
europepmc +1 more source
5-HT2A Receptor Knockout Mice Show Sex-Dependent Differences following Acute Noribogaine Administration. [PDF]
Villalba S +9 more
europepmc +1 more source
The Selective Serotonin 5‑HT<sub>2A</sub> Receptor Agonist (<i>S</i>)‑3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents. [PDF]
Jensen AA +8 more
europepmc +1 more source
Structure-Based Identification of Aporphines With Selective 5-HT2A Receptor-Binding Activity
Selective blockade of the serotonin 5-HT2A receptor is a useful therapeutic approach for a number of disorders, including schizophrenia, insomnia and ischaemic heart disease.
Lip Yong Chung +2 more
exaly +4 more sources
Related searches:
“Selective” serotonin 5-HT2A receptor antagonists
Biochemical Pharmacology, 2022Blockade of the serotonin 5-HT2A G protein-coupled receptor (5-HT2AR) is a fundamental pharmacological characteristic of numerous antipsychotic medications, which are FDA-approved to treat schizophrenia, bipolar disorder, and as adjunctive therapies in major depressive disorder.
Austen B, Casey +3 more
openaire +2 more sources

